FTC opens investigation into Teva, escalating patent fight with pharma industry
Democrats have accused drug companies of “junk patent listings,” arguing that the industry is blocking generic competition and inflating patients’ costs.
http://washingtonpost.com/health/2024/07/01/teva-patent-pharma-generic-inhaler/?gaa_at=la&gaa_n=ARTJ-U9wgnTOF-ZrRCe90ocA0__CS0I8bt1E4w3-Ti935uhPTPKWP6vTra0XDqHHd3s%3D&gaa_
Cell Therapy News/Articles, page-17806
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |